Christopher M. Brede
Expertise in
23
conditions

Dr. Christopher M. Brede

Oncology | Urology
1900 Wealthy Street Southeast, Suite 100, 
Grand Rapids, MI 
Accepting New Patients
Offers Telehealth
17 Years of Experience
Referral may be required
Before you request
Expertise in
23
conditions
1900 Wealthy Street Southeast, Suite 100, 
Grand Rapids, MI 

Overview

Christopher Brede is an Oncologist and a Urologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 17 years.

Dr. Brede is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery.

Dr. Brede is board certified in American Board Of Urology. He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 1 clinical trial. Dr. Brede is currently accepting new patients.

Graduate Year

2009

Specialties

Oncology
Urology

Licenses

Urology in MI

Board Certifications

American Board Of Urology

Hospital Affiliations

Corewell Health Grand Rapids Hospitals
Corewell Health Zeeland Hospital
Corewell Health Rehab And Nursing Centers
Spectrum Health
Spectrum Health United Hospital
Corewell Health Pennock Hospital
Corewell Health Reed City Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Corewell Health Urology - Wealthy
1900 Wealthy Street Southeast, Suite 100, Grand Rapids, MI 49506

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Prospective, Open-label Randomized Clinical Trial of a Single Bladder Instillation of Mitomycin C vs. Gemcitabine vs. No Additional Treatment Immediately After Transurethral Resection of Bladder Tumor (TURBT)
A Prospective, Open-label Randomized Clinical Trial of a Single Bladder Instillation of Mitomycin C vs. Gemcitabine vs. No Additional Treatment Immediately After Transurethral Resection of Bladder Tumor (TURBT)
Enrollment Status: Completed
Publish Date: April 21, 2023
Intervention Type: Drug
Study Drugs: Mitomycin C, Gemcitabine
Study Phase: Phase 3

12 Total Publications

Partial Nephrectomy as Management of Oligometastatic Cancer with Limited Systemic Treatment Options: A Case Report.
Partial Nephrectomy as Management of Oligometastatic Cancer with Limited Systemic Treatment Options: A Case Report.
Journal: Journal of kidney cancer and VHL
Published: May 25, 2025
Similar Doctors
Expertise in
17
conditions
Dr. Conrad M. Tobert
Oncology | Urology
Expertise in
17
conditions
Dr. Conrad M. Tobert
Oncology | Urology
Referral may be required
Before you request

Corewell Health Urology - Wealthy

1900 Wealthy Street Southeast, Suite 100, 
Grand Rapids, MI 
 (0.1 miles away)
616-267-7333
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Conrad Tobert is an Oncologist and a Urologist practicing medicine in Grand Rapids, Michigan. Dr. Tobert is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Nephrectomy, and Ureteroscopy. Dr. Tobert is board certified in American Board Of Urology. Dr. Tobert is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral required
Before you request

The Cancer & Hematology Centers

710 Kenmoor Avenue Southeast, Suite 200, 
Grand Rapids, MI 
 (4.4 miles away)
616-389-1800
Languages Spoken:
English, Croatian
See accepted insurances
Accepting New Patients

Eric Santos is an Oncologist practicing medicine in Grand Rapids, Michigan. Dr. Santos is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, Colorectal Cancer, and Awake Craniotomy. Dr. Santos is board certified in American Board Of Internal Medicine. Dr. Santos is currently accepting new patients.

Expertise in
47
conditions
Dr. Erin M. Pettijohn
Oncology | Hematology Oncology | Hematology
Expertise in
47
conditions
Dr. Erin M. Pettijohn
Oncology | Hematology Oncology | Hematology
Referral may be required
Before you request

The Cancer & Hematology Centers

145 Michigan Street Northeast, Suite 3100, 
Grand Rapids, MI 
 (2.6 miles away)
616-954-9800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Erin Pettijohn is an Oncologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. Dr. Pettijohn is highly rated in 47 conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Pettijohn is board certified in American Board Of Internal Medicine. Dr. Pettijohn is currently accepting new patients.

Frequently Asked Questions about Dr. Christopher M. Brede

How do I make an appointment with Dr. Christopher M. Brede?

You can book an appointment with Dr. Christopher M. Brede by calling their office at 616-267-7333. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Christopher M. Brede a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher M. Brede is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Christopher M. Brede specialize in?

While Dr. Christopher M. Brede is a Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Renal Cell Carcinoma (RCC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Christopher M. Brede participate in research or clinical trials?

Yes. Dr. Christopher M. Brede has published 12 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Christopher M. Brede's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Christopher M. Brede accept my insurance?

Dr. Christopher M. Brede accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 616-267-7333 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Brede's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile